Home
>
National Drug Code (NDC)
>
VALTREX
VALTREX - 55289-926-08 - (valacyclovir hydrochloride)
Drug Information of VALTREX
| Product NDC: | 55289-926 |
| Proprietary Name: | VALTREX |
| Non Proprietary Name: | valacyclovir hydrochloride |
| Active Ingredient(s): | 500 mg/1 & nbsp; valacyclovir hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of VALTREX
| Product NDC: | 55289-926 |
| Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020487 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19950801 |
Package Information of VALTREX
| Package NDC: | 55289-926-08 |
| Package Description: | 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-926-08) |
NDC Information of VALTREX
| NDC Code | 55289-926-08 |
| Proprietary Name | VALTREX |
| Package Description | 8 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-926-08) |
| Product NDC | 55289-926 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | valacyclovir hydrochloride |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19950801 |
| Marketing Category Name | NDA |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Substance Name | VALACYCLOVIR HYDROCHLORIDE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient] |
